Company / Shareholders' Equity
vTv Therapeutics Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$64.4M
FY2025
5-year range
-$80.1M / $64.4M
FY2021-FY2025
Trend
+428.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +428% YoY in FY2025, a notable deviation from the 9-year average annual change of +75%.
Based on SEC 10-K filings.
$64M in FY2025.
Improved from -$25M to $64M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- vTv Therapeutics Inc.'s shareholders' equity has grown for 3 consecutive years.
- In FY2025, shareholders' equity increased 428.2% year-over-year.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.4M | +428.2% |
| FY2024 | $12.2M | +149.4% |
| FY2023 | -$24.7M | +69.2% |
| FY2022 | -$80.1M | -63.4% |
| FY2021 | -$49.0M | +40.8% |
| FY2020 | -$82.9M | +45.1% |
| FY2019 | -$151.0M | -66.1% |
| FY2018 | -$90.9M | -16.6% |
| FY2017 | -$78.0M | +84.4% |
| FY2016 | -$498.8M | -64.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026